Open innovation and firms' performance: State of the art and empirical evidences from the bio-pharmaceutical industry

Risultato della ricerca: Article

9 Citazioni (Scopus)

Abstract

The research presented in this paper explores the effect of inbound, outbound and coupled open innovation practices on firms' performances in the biopharmaceutical industry. Specifically, although existing researches on open innovation effectiveness have separately investigated the effect of open innovation practices on innovation and financial performance, this study evaluates the concurrent effect of these practices on both such performance dimensions in a single framework. We state the importance for a manager to explore concurrently the influence of specific open innovation practices both on innovation and economic-financial performance. We empirically test our framework on a sample of 120 companies listed on the NASDAQ biotechnology index.
Lingua originaleEnglish
pagine (da-a)109-134
Numero di pagine26
RivistaInternational Journal of Technology Management
Volume70
Stato di pubblicazionePublished - 2016

Fingerprint

pharmaceutical industry
Drug products
Innovation
innovation
firm
performance
evidence
Industry
Biotechnology
biotechnology
Biopharmaceutical industry
Open innovation
Empirical evidence
Firm performance
Managers
manager
Economics
industry
economics
Financial performance

All Science Journal Classification (ASJC) codes

  • Industrial relations
  • Engineering(all)
  • Computer Science Applications
  • Strategy and Management
  • Law

Cita questo

@article{f32a08fee1ff4daa8a77645cb567c868,
title = "Open innovation and firms' performance: State of the art and empirical evidences from the bio-pharmaceutical industry",
abstract = "The research presented in this paper explores the effect of inbound, outbound and coupled open innovation practices on firms' performances in the biopharmaceutical industry. Specifically, although existing researches on open innovation effectiveness have separately investigated the effect of open innovation practices on innovation and financial performance, this study evaluates the concurrent effect of these practices on both such performance dimensions in a single framework. We state the importance for a manager to explore concurrently the influence of specific open innovation practices both on innovation and economic-financial performance. We empirically test our framework on a sample of 120 companies listed on the NASDAQ biotechnology index.",
author = "Manfredi Bruccoleri and Erica Mazzola and Giovanni Perrone",
year = "2016",
language = "English",
volume = "70",
pages = "109--134",
journal = "International Journal of Technology Management",
issn = "0267-5730",
publisher = "Inderscience Enterprises Ltd",

}

TY - JOUR

T1 - Open innovation and firms' performance: State of the art and empirical evidences from the bio-pharmaceutical industry

AU - Bruccoleri, Manfredi

AU - Mazzola, Erica

AU - Perrone, Giovanni

PY - 2016

Y1 - 2016

N2 - The research presented in this paper explores the effect of inbound, outbound and coupled open innovation practices on firms' performances in the biopharmaceutical industry. Specifically, although existing researches on open innovation effectiveness have separately investigated the effect of open innovation practices on innovation and financial performance, this study evaluates the concurrent effect of these practices on both such performance dimensions in a single framework. We state the importance for a manager to explore concurrently the influence of specific open innovation practices both on innovation and economic-financial performance. We empirically test our framework on a sample of 120 companies listed on the NASDAQ biotechnology index.

AB - The research presented in this paper explores the effect of inbound, outbound and coupled open innovation practices on firms' performances in the biopharmaceutical industry. Specifically, although existing researches on open innovation effectiveness have separately investigated the effect of open innovation practices on innovation and financial performance, this study evaluates the concurrent effect of these practices on both such performance dimensions in a single framework. We state the importance for a manager to explore concurrently the influence of specific open innovation practices both on innovation and economic-financial performance. We empirically test our framework on a sample of 120 companies listed on the NASDAQ biotechnology index.

UR - http://hdl.handle.net/10447/213435

M3 - Article

VL - 70

SP - 109

EP - 134

JO - International Journal of Technology Management

JF - International Journal of Technology Management

SN - 0267-5730

ER -